ARDX
Ardelyx, Inc. Healthcare - Biotechnology Investor Relations →
Ardelyx, Inc. (ARDX) closed at $7.32 as of 2026-02-02, trading 60.7% above its 200-week moving average of $4.56. The stock is currently moving closer to the line, down from 70.0% last week. The 14-week RSI sits at 59, indicating neutral momentum.
Over the past 559 weeks of data, ARDX has crossed below its 200-week moving average 14 times. On average, these episodes lasted 25 weeks. The average one-year return after crossing below was -4.1%, suggesting these dips have not historically been reliable buying opportunities for this stock.
With a market cap of $1779 million, ARDX is a small-cap stock. Free cash flow yield is currently negative, meaning the company is burning cash. Return on equity stands at -36.2%. The stock trades at 11.5x book value.
Share count has increased 82.8% over three years, indicating dilution.
Over the past 10.8 years, a hypothetical investment of $100 in ARDX would have grown to $67, compared to $392 for the S&P 500. ARDX has returned -3.6% annualized vs 13.4% for the index, underperforming the broader market over this period.
In the past 12 months, corporate insiders have made 5 open-market purchases totaling $3,791,934.
Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.
Growth of $100: ARDX vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After ARDX Crosses Below the Line?
Across 14 historical episodes, buying ARDX when it crossed below its 200-week moving average produced an average return of -7.6% after 12 months (median -18.0%), compared to +22.2% for the S&P 500 over the same periods. 42% of those episodes were profitable after one year. After 24 months, the average return was -40.1% vs +38.6% for the index.
Each line shows $100 invested at the moment ARDX crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
ARDX has crossed below its 200-week MA 14 times with an average 1-year return of +-4.1% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| May 2015 | Jul 2015 | 8 | 37.6% | -19.2% | -33.2% |
| Aug 2015 | Aug 2015 | 1 | 0.3% | -43.1% | -58.0% |
| Oct 2015 | Nov 2015 | 2 | 10.5% | -16.7% | -53.8% |
| Nov 2015 | Nov 2015 | 1 | 2.6% | -11.0% | -57.6% |
| Jan 2016 | Nov 2016 | 44 | 57.9% | +29.2% | -31.7% |
| Nov 2016 | Dec 2019 | 158 | 82.8% | -55.7% | -50.5% |
| Mar 2020 | Apr 2020 | 6 | 19.3% | +6.5% | +16.9% |
| Apr 2020 | May 2020 | 1 | 0.6% | +13.5% | +13.7% |
| Jul 2020 | Nov 2020 | 15 | 10.2% | -69.2% | +29.6% |
| Jul 2021 | Mar 2023 | 88 | 86.6% | -58.6% | +335.7% |
| May 2023 | Aug 2023 | 15 | 20.3% | +120.0% | +106.2% |
| Sep 2023 | Nov 2023 | 8 | 16.7% | +55.2% | +85.3% |
| May 2025 | May 2025 | 1 | 3.5% | N/A | +102.2% |
| May 2025 | Jun 2025 | 5 | 6.0% | N/A | +99.5% |
| Average | 25 | — | +-4.1% | — |
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of Friday close, 2026-02-02